广西梧州制药（集团）股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
310
NMPA:310
Drug Approvals
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字H45020151
- Approval Date
- Jun 28, 2021
NMPA
Erythromycin Lactobionate for Injection
- Product Name
- 注射用乳糖酸红霉素
- Approval Number
- 国药准字H45021339
- Approval Date
- Jun 28, 2021
NMPA
Cefoperazone Sodium for Injection
- Product Name
- 注射用头孢哌酮钠
- Approval Number
- 国药准字H45020779
- Approval Date
- Jun 28, 2021
NMPA
Amikacin Sulfate for Injection
- Product Name
- 注射用硫酸阿米卡星
- Approval Number
- 国药准字H45020194
- Approval Date
- Jun 28, 2021
NMPA
Erythromycin Lactobionate for Injection
- Product Name
- 注射用乳糖酸红霉素
- Approval Number
- 国药准字H45021338
- Approval Date
- Jun 28, 2021
NMPA
Cefoperazone Sodium for Injection
- Product Name
- 注射用头孢哌酮钠
- Approval Number
- 国药准字H45020778
- Approval Date
- Jun 28, 2021
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 31
- Next
Clinical Trials
No trials found
News
No news found